GenFlow Biosciences Overview
- Year Founded
-
2020
- Status
-
Public
- Employees
-
5
- Stock Symbol
-
GENF
- Share Price
-
$0.02
- (As of Friday Closing)
GenFlow Biosciences General Information
Description
Genflow Biosciences PLC is a preclinical biotechnology company focused on the development of biological interventions (namely gene therapies) which are aimed at tackling the effects of aging, potentially slowing or halting the aging process and so reducing the incidence of age-related diseases and thereby increasing health span. Its flagship compound, GF-1002, is based on the delivery of a variant of the SIRT6 gene and is currently in preclinical development.
Contact Information
Website
www.genflowbio.comCorporate Office
- 6 Heddon Street
- London W1B 4BT
- England, United Kingdom
Corporate Office
- 6 Heddon Street
- London W1B 4BT
- England, United Kingdom
GenFlow Biosciences Stock Performance
As of 13-Nov-2026, GenFlow Biosciences’s stock price is $0.02. Its current market cap is $13M with 595M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.02 | $0.02 | $0.02 - $0.04 | $13M | 595M | 2.19M |
GenFlow Biosciences Financials Summary
As of 30-Jun-2026, GenFlow Biosciences has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 16,742 | 11,919 | 6,139 | 3,388 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (1,475) | (1,866) | (2,027) | (2,311) |
| Net Income | (1,476) | (1,867) | (2,028) | (2,312) |
| Total Assets | 993 | 609 | 484 | 1,365 |
| Total Debt | 0 | 0 | 0 | 0 |
GenFlow Biosciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
GenFlow Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
GenFlow Biosciences Patents
GenFlow Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026062177-A1 | Variants of sirtuin 6 for the treatment of muscular diseases | Pending | 20-Sep-2024 | ||
| AU-2023389400-A1 | Variants of sirtuin 6 for the treatment of non-alcoholic fatty liver disease | Pending | 08-Dec-2022 | ||
| EP-4630038-A1 | Variants of sirtuin 6 for the treatment of non-alcoholic fatty liver disease | Pending | 08-Dec-2022 | ||
| US-20260199524-A1 | Variants of sirtuin 6 for the treatment of non-alcoholic fatty liver disease | Pending | 08-Dec-2022 | ||
| WO-2024121363-A1 | Variants of sirtuin 6 for the treatment of non-alcoholic fatty liver disease | Inactive | 08-Dec-2022 | A61K38/43 |
GenFlow Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
GenFlow Biosciences ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
GenFlow Biosciences FAQs
-
When was GenFlow Biosciences founded?
GenFlow Biosciences was founded in 2020.
-
Where is GenFlow Biosciences headquartered?
GenFlow Biosciences is headquartered in London, United Kingdom.
-
What is the size of GenFlow Biosciences?
GenFlow Biosciences has 5 total employees.
-
What industry is GenFlow Biosciences in?
GenFlow Biosciences’s primary industry is Biotechnology.
-
Is GenFlow Biosciences a private or public company?
GenFlow Biosciences is a Public company.
-
What is GenFlow Biosciences’s stock symbol?
The ticker symbol for GenFlow Biosciences is GENF.
-
What is the current stock price of GenFlow Biosciences?
As of 13-Nov-2026 the stock price of GenFlow Biosciences is $0.02.
-
What is the current market cap of GenFlow Biosciences?
The current market capitalization of GenFlow Biosciences is $13M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
